ORIOLA Oriola Oyj
Single AI model preview (DeepSeek): Oriola Oyj estimate 1.68 € vs market price 0.93 € (+81.6%). Analyst coverage: 3. Experimental research — not investment advice.
About the company
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.
Model assumptions (DeepSeek)
Weekly snapshots
| Date | Spot | Preview est. | Gap |
|---|---|---|---|
| 2026-07-11 | 0.93 € | 1.68 € | +81.6% |
| 2026-07-04 | 0.95 € | 1.68 € | +76.8% |
| 2026-07-03 | 0.95 € | 1.68 € | +77.4% |
| 2026-07-02 | 0.93 € | 1.68 € | +79.9% |